Mazindol in Children With Attention Deficit Hyperactivity Disorder Design Study to Explore the Effectiveness, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Two Orally Administered Doses of Mazindol.
Phase of Trial: Phase II
Latest Information Update: 23 Dec 2014
At a glance
- Drugs Mazindol (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Therapeutic Use
- Acronyms MAZDAH
- 02 Oct 2009 Actual initiation date (Mar 2008) added as reported by ClinicalTrials.gov.
- 02 Oct 2009 Actual end date (Jul 2009) added as reported by ClinicalTrials.gov.
- 02 Oct 2009 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.